Why Novo Nordisk’s CEO has learned to trust his gut feeling
Update: 2024-05-28
Description
Lars Fruergaard Jørgensen, CEO of the company which makes game-changing obesity drugs Ozempic and Wegovy, explains how its culture and long-view underpin its recent turnaround.
Comments
In Channel